GHDx
Published on GHDx (https://ghdx.healthdata.org)


Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design

General Info

Geography 
Denmark (DNK)
Finland (FIN)
Iceland (ISL)
Norway (NOR)
Sweden (SWE)
Time period covered 
January, 1996 - December, 2010
Data type
Scientific literature
Keywords 
Congenital anomalies, Congenital heart anomalies

Citation

Authors 
Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M
Journal 
BMJ
Pages 
h1798
Publication year 
2015
Suggested citation 
Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015; 350: h1798.

Source URL: https://ghdx.healthdata.org/record/selective-serotonin-reuptake-inhibitors-and-venlafaxine-early-pregnancy-and-risk-birth#comment-0